share_log

Invivyd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Maverick Capital, Ltd.(9.9%),Maverick Capital Management, LLC(9.9%), etc.

Invivyd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Maverick Capital, Ltd.(9.9%),Maverick Capital Management, LLC(9.9%), etc.

Invivyd | SC 13G/A:超過5%持股股東披露文件(修正)-Maverick Capital, Ltd.(9.9%),Maverick Capital Management, LLC(9.9%)等
美股SEC公告 ·  11/15 05:37

Moomoo AI 已提取核心訊息

On September 30, 2024, Invivyd, Inc., a company specializing in biotechnology with its principal executive offices located in Waltham, MA, was the subject of a Schedule 13G/A filing with the United States Securities and Exchange Commission. The filing was made by Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III, indicating a shared voting and dispositive power over 11,765,787 shares of Invivyd's common stock, which represents 9.9% of the class. The shares are held for the accounts of Maverick Capital, Ltd.'s clients. Maverick Capital, Ltd. is an investment adviser with beneficial ownership of the shares through the investment discretion it exercises over its clients' accounts. Maverick Capital Management, LLC is the General Partner of Maverick Capital, Ltd., and Mr...Show More
On September 30, 2024, Invivyd, Inc., a company specializing in biotechnology with its principal executive offices located in Waltham, MA, was the subject of a Schedule 13G/A filing with the United States Securities and Exchange Commission. The filing was made by Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III, indicating a shared voting and dispositive power over 11,765,787 shares of Invivyd's common stock, which represents 9.9% of the class. The shares are held for the accounts of Maverick Capital, Ltd.'s clients. Maverick Capital, Ltd. is an investment adviser with beneficial ownership of the shares through the investment discretion it exercises over its clients' accounts. Maverick Capital Management, LLC is the General Partner of Maverick Capital, Ltd., and Mr. Ainslie is the manager of Maverick Capital Management, LLC. The ownership reported is based on 119,442,635 outstanding shares as disclosed in Invivyd's Quarterly Report filed on August 14, 2024. The filing asserts that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Invivyd, Inc.
在2024年9月30日,Invivyd, Inc.是一家專注於生物技術的公司,主要行政辦公室位於馬薩諸塞州沃爾瑟姆,該公司向美國證券交易委員會提交了Schedule 13G/A申請。該申請由Maverick Capital, Ltd.、Maverick Capital Management, LLC以及Lee S. Ainslie III提交,表明對11,765,787股Invivyd普通股擁有共同投票和處置權,代表該類別的9.9%。這些股份是爲Maverick Capital, Ltd.客戶的帳戶持有的。Maverick Capital, Ltd.是一家投資顧問,通過其對客戶帳戶的投資決策擁...展開全部
在2024年9月30日,Invivyd, Inc.是一家專注於生物技術的公司,主要行政辦公室位於馬薩諸塞州沃爾瑟姆,該公司向美國證券交易委員會提交了Schedule 13G/A申請。該申請由Maverick Capital, Ltd.、Maverick Capital Management, LLC以及Lee S. Ainslie III提交,表明對11,765,787股Invivyd普通股擁有共同投票和處置權,代表該類別的9.9%。這些股份是爲Maverick Capital, Ltd.客戶的帳戶持有的。Maverick Capital, Ltd.是一家投資顧問,通過其對客戶帳戶的投資決策擁有股份的實益所有權。Maverick Capital Management, LLC是Maverick Capital, Ltd.的普通合夥人,Ainslie先生是Maverick Capital Management, LLC的經理。報告的持有量基於根據2024年8月14日提交的Invivyd季度報告所披露的119,442,635股流通股份。該申請聲明,這些股份是在正常的業務過程中獲得並持有,並非爲了改變或影響Invivyd, Inc.的控制權。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息